Evolving clinical phenotypes in HIV-associated neurocognitive disorders - sprookjes - yvandenbroek - TriplyDB

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

http://www.wikidata.org/entity/Q26859192

about

The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections.Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques.Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.Neurocognitive profile of HIV-positive adults on combined antiretroviral therapy: A single-centre study in Serbia.Temporal processsing demands in the HIV-1 transgenic rat: Amodal gating and implications for diagnostics.Novel insights into role of miR-320a-VDAC1 axis in astrocyte-mediated neuronal damage in neuroAIDS.Impairments in Component Processes of Executive Function and Episodic Memory in Alcoholism, HIV Infection, and HIV Infection with Alcoholism Comorbidity.A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations.Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV).Sex Matters: Robust Sex Differences in Signal Detection in the HIV-1 Transgenic Rat.Unraveling Individual Differences In The HIV-1 Transgenic Rat: Therapeutic Efficacy Of Methylphenidate.Human Immunodeficiency Virus in the Brain-Culprit or Facilitator?

P2860

Q28066725-FA8323E1-4CC8-4617-8437-182858F14704 Q36169735-58CAFBF7-8827-468E-AEB9-4B6F4C368398 Q37182704-5B963ACC-CC33-4199-B2FD-57297D296CC2 Q37646891-CEA0FAD1-1101-4B2C-8647-386625B30387 Q38414364-8D3E766E-7475-4FB5-8BE0-D5C8E8BC731C Q38916260-482DC6AD-F1F8-4C4A-AE7F-38D46CA3ED2F Q40152423-0967FCBA-C584-41F9-93E7-33A99DEDD7AA Q40400564-2751A161-25C5-4444-984E-146347CF928B Q40497318-BCB554AB-8E3D-4C29-9E1A-CAA38F768C2F Q40498240-73789DA6-750E-498D-A45F-D865506CD889 Q40798405-8053FDD5-AC5E-49F3-BEDD-26A05781AA0D Q41208022-7256F23D-164B-4F1E-A4D9-279E9BBFF1AE Q41551768-755BE3CF-7BCD-445C-AD6A-1E8A466C59C8 Q47574273-1B0649B1-DE4D-488B-8D7F-44C1754864B7 Q47873338-279D2B5D-6110-47A8-86E7-85B56FBE29B3 Q50200827-A2B641AA-975F-447C-9834-882BAEC4BF7F

P2860

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

http://www.wikidata.org/entity/Q26859192

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@ast

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@en

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@nl

type

label

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@ast

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@en

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@nl

prefLabel

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@ast

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@en

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@nl

P1433

Q26859192-52B96AC3-410C-44EF-B0B1-1488E1B90D0B

P1476

Q26859192-D5A9BD32-4C8E-4463-9BE9-73E86FDF7FDF

P2093

Q26859192-A9353131-85AF-403B-9256-7E3CF84BAA0F

P2860

Q26859192-15482626-8D01-4194-A7E0-1588456C7A8A

Q26859192-15FB8BE4-2533-4857-969E-919EA6DF558B

Q26859192-19C9BF36-43BB-4BDF-A317-6F5F22BF713C

Q26859192-19F76178-2369-4746-9E66-045A92B56670

Q26859192-20F09A8A-3503-4BEE-BE25-31C4837CEFB1

Q26859192-2A292E0C-12A3-4D6D-B31F-0E70FC02DE11

Q26859192-2C550C06-DC63-4204-AA8D-BA99B7AB50E9

Q26859192-3962F8BA-96E3-45AB-9BEF-2E93FD356408

Q26859192-4C09B995-2A4E-41A0-BE2C-11E000DCD937

Q26859192-5289AFD0-FED2-4128-AD62-52026ED4DA28

P304

Q26859192-C79F998D-8EA3-4F8A-8812-18D7DCB5D105

P31

Q26859192-6BC5F6BC-0E02-4DCA-B2DD-37457EEF87ED

Q26859192-b5bbc063-9d43-4117-ab52-5730a04f2095

P356

Q26859192-57609549-B6CA-4FE6-B984-4A85B4D1A3A9

P407

Q26859192-72233BEC-44B0-4589-A070-A84A6EA7163F

P433

Q26859192-0007F6BA-3498-492B-8F17-BCF137B34055

P478

Q26859192-4CC95BE5-EF94-466B-9001-E44515F3E6EF

P50

Q26859192-58D02608-1C44-4B8E-9463-1FBDA131642E

P577

Q26859192-DDF5F8C0-3AB1-41C9-AFDB-B6BA571AB509

P698

Q26859192-81A0A92C-0A0E-440A-A747-CC0C9CA646A1

P932

Q26859192-17235273-D2CA-47F9-B7CE-2BF1CF12481C

P356

COH.0000000000000102

P1433

Current Opinion in HIV and AIDS

P1476

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

@en

P2093

Kevin Robertson

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Pattern of neuropsychological performance among HIV positive patients in Uganda.

Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power.

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.

P304

517-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/COH.0000000000000102

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25203640

http://www.w3.org/2001/XMLSchema#string

P932

4212639

http://www.w3.org/2001/XMLSchema#string